EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pre-eclampsia: Re-visiting pathophysiology, role of immune cells, biomarker identification and recent advances in its management

Palanisamy Tamil Barathi, Arumugam Mohanapriya

Journal of Reproductive Immunology · 2024

DOI: 10.1016/j.jri.2024.104236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Reproductive Immunology, 2024. Verfasst von Palanisamy Tamil Barathi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, India. Electronic address: tamilb…. Hauptthemen laut MEDLINE: Biomarkers, Pre-Eclampsia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: VIT University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pre-eclampsia (PE) is a hypertension condition that occurs exclusively during pregnancy and has the potential to impact nearly all organ systems. It is estimated to complicate approximately 2-8% of pregnancies worldwide. PE is a prominent medical disorder that poses a significant risk to pregnant mothers and their infants. This review commences by giving the most up-to- date concepts about the pathophysiology of PE. The condition involves atypical infiltration of trophoblast cells into the spiral arteries of the decidua and myometrium, resulting in an insufficient establishment of proper blood flow between the uterus and placenta. The aberrant activation of natural killer (NK) cells in both the peripheral blood and the decidua has been identified as one of the contributing factors to the development of PE. The strong evidence for the genetic etiology of PE is provided by the association between maternal killer cell immunoglobulin-like receptor (KIR) and Human Leukocyte Antigen (HLA-C) in trophoblast cells. Recent observations provide evidence that changes in the expression of anti-angiogenic factors in the placenta are the underlying cause of the clinical symptoms associated with the condition. This review also provides a comprehensive overview of the latest advancements in understanding the underlying causes of PE. It specifically highlights the emergence of new diagnostic biomarkers and their potential implications for therapeutic interventions in managing this medical condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersPre-EclampsiaAnimalsFemaleHumansPregnancyDeciduaHLA-C AntigensKiller Cells, NaturalPlacentaReceptors, KIRTrophoblasts

Stichwörter der Autor:innen

BiomarkersHuman Leukocyte Antigen-C (HLA-C)Killer cell immunoglobulin-like Receptor (KIR)Natural Killer Cells (NK)Pre-eclampsia (PE)Trophoblast

Substanzen

BiomarkersHLA-C AntigensReceptors, KIR

Autor:innen und Institutionen

  • Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, India. Electronic address: tamilbarathi.p2022@vitstudent.ac.in.
  • Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore 632014, India. Electronic address: mohanapriyaa@vit.ac.in.

Förderung

  • VIT University

Zitieren

APA

Tamil Barathi, P., & Mohanapriya, A. (2024). Pre-eclampsia: Re-visiting pathophysiology, role of immune cells, biomarker identification and recent advances in its management. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2024.104236

Vancouver

Tamil Barathi P, Mohanapriya A. Pre-eclampsia: Re-visiting pathophysiology, role of immune cells, biomarker identification and recent advances in its management. Journal of Reproductive Immunology. 2024. doi:10.1016/j.jri.2024.104236

BibTeX
@article{TamilBarathi2024,
  author = {Tamil Barathi, Palanisamy and Mohanapriya, Arumugam},
  title = {Pre-eclampsia: Re-visiting pathophysiology, role of immune cells, biomarker identification and recent advances in its management},
  journal = {Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1016/j.jri.2024.104236}
}
Kostenlos starten →